ID: ALA4746142

Max Phase: Preclinical

Molecular Formula: C58H91N17O12S2

Molecular Weight: 1282.61

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CSCC[C@H](NC(=O)[C@@H](N)CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O)C(C)C

Standard InChI:  InChI=1S/C58H91N17O12S2/c1-32(2)25-39(69-53(83)44-17-11-22-74(44)55(85)38(19-24-89-5)67-48(78)36(59)30-88)50(80)68-40(27-35-28-63-31-65-35)51(81)71-42(29-76)52(82)66-37(15-9-20-64-58(61)62)49(79)72-46(33(3)4)57(87)75-23-12-18-45(75)54(84)70-41(26-34-13-7-6-8-14-34)56(86)73-21-10-16-43(73)47(60)77/h6-8,13-14,28,31-33,36-46,76,88H,9-12,15-27,29-30,59H2,1-5H3,(H2,60,77)(H,63,65)(H,66,82)(H,67,78)(H,68,80)(H,69,83)(H,70,84)(H,71,81)(H,72,79)(H4,61,62,64)/t36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1

Standard InChI Key:  SUWXGFJVTBICKW-HDKAIKTRSA-N

Associated Targets(Human)

Apelin receptor 3301 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Apelin receptor 201 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NRK-52E 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1282.61Molecular Weight (Monoisotopic): 1281.6475AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C,Xiong M,Yang C,Yang D,Zheng J,Fan Y,Wang S,Gai Y,Lan X,Chen H,Zheng L,Huang K.  (2020)  PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury.,  63  (24.0): [PMID:33290073] [10.1021/acs.jmedchem.0c01913]

Source